Filtros de búsqueda

Lista de obras de Luis M Blanco-Colio

3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase and Isoprenylation Inhibitors Induce Apoptosis of Vascular Smooth Muscle Cells in Culture

article

3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation

artículo científico publicado en 2002

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase the binding activity and nuclear level of Oct-1 in mononuclear cells

artículo científico publicado en 2002

3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors decrease Fas ligand expression and cytotoxicity in activated human T lymphocytes.

artículo científico publicado en 2003

A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty restenosis

artículo científico publicado en 2019

A slit in podocyte death

scientific article published on January 2008

AKI associated with macroscopic glomerular hematuria: clinical and pathophysiologic consequences

artículo científico publicado en 2011

Additive effects of soluble TWEAK and inflammation on mortality in hemodialysis patients

artículo científico publicado en 2008

Adiponectin plasma levels are increased by atorvastatin treatment in subjects at high cardiovascular risk

artículo científico publicado en 2008

Animal models of cardiovascular diseases

artículo científico publicado en 2011

Anti-inflammatory and immunomodulatory effects of statins.

artículo científico publicado en 2003

ApoA-I/HDL-C levels are inversely associated with abdominal aortic aneurysm progression

artículo científico publicado en 2015

Assessment of biomarkers and predictive model for short-term prospective abdominal aortic aneurysm growth-A pilot study

artículo científico publicado en 2014

Association of ficolin-3 with abdominal aortic aneurysm presence and progression.

artículo científico publicado en 2016

Atorvastatin decreases elevated soluble CD40L in subjects at high cardiovascular risk. Atorvastatin on inflammatory markers study: a substudy of ACTFAST.

artículo científico publicado en 2008

Atorvastatin modulates the profile of proteins released by human atherosclerotic plaques

artículo científico publicado en 2007

Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells.

artículo científico publicado en 2002

Atorvastatin reduces the expression of prostaglandin E2 receptors in human carotid atherosclerotic plaques and monocytic cells: potential implications for plaque stabilization

artículo científico publicado en 2006

Bcl-xL overexpression protects from apoptosis induced by HMG-CoA reductase inhibitors in murine tubular cells

artículo científico publicado en 2003

Biological Significance of Decreased HSP27 in Human Atherosclerosis

artículo científico publicado en 2006

Biology of atherosclerotic plaques: what we are learning from proteomic analysis

artículo científico publicado en 2006

Biomarkers in cardiovascular medicine

artículo científico publicado en 2009

Butter and walnuts, but not olive oil, elicit postprandial activation of nuclear transcription factor kappaB in peripheral blood mononuclear cells from healthy men

artículo científico publicado en 2004

Cardiovascular risk and antiangiogenic therapy for age-related macular degeneration.

artículo científico publicado en 2009

Cell stress proteins in atherothrombosis

artículo científico publicado en 2012

Combination of biomarkers of vascular calcification and sTWEAK to predict cardiovascular events in chronic kidney disease.

artículo científico publicado en 2018

Combined therapy with renin-angiotensin system and calcium channel blockers in type 2 diabetic hypertensive patients with proteinuria: effects on soluble TWEAK, PTX3, and flow-mediated dilation

artículo científico publicado en 2010

Common pathways of hypercholesterolemia and hypertension leading to atherothrombosis: the need for a global approach in the management of cardiovascular risk factors.

artículo científico publicado en 2007

Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis

artículo científico publicado en 2003

Considering TWEAK as a target for therapy in renal and vascular injury

artículo científico publicado en 2009

Decreased circulating Fas ligand in patients with familial combined hyperlipidemia or carotid atherosclerosis: normalization by atorvastatin

artículo científico publicado en 2004

Differential profile in inflammatory and mineral metabolism biomarkers in patients with ischemic heart disease without classical coronary risk factors.

artículo científico publicado en 2014

Effect of atorvastatin on circulating hsCRP concentrations: a sub-study of the achieve cholesterol targets fast with atorvastatin stratified titration (ACTFAST) study

artículo científico publicado en 2009

Effect of intensive atorvastatin therapy on prostaglandin E2 levels and metalloproteinase-9 activity in the plasma of patients with non-ST-elevation acute coronary syndrome.

artículo científico publicado en 2008

Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on Inflammatory Markers study: a substudy of Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titrati

artículo científico publicado en 2007

Erythrocytes, leukocytes and platelets as a source of oxidative stress in chronic vascular diseases: detoxifying mechanisms and potential therapeutic options.

artículo científico publicado en 2012

Essential role of TGF-beta/Smad pathway on statin dependent vascular smooth muscle cell regulation

artículo científico publicado en 2008

Ethanol beverages containing polyphenols decrease nuclear factor kappa-B activation in mononuclear cells and circulating MCP-1 concentrations in healthy volunteers during a fat-enriched diet

artículo científico publicado en 2006

Fn14 is upregulated in cytokine-stimulated vascular smooth muscle cells and is expressed in human carotid atherosclerotic plaques: modulation by atorvastatin

artículo científico publicado en 2006

From tissue iron retention to low systemic haemoglobin levels, new pathophysiological biomarkers of human abdominal aortic aneurysm

artículo científico publicado en 2014

Galectin-3 Is Associated with Cardiovascular Events in Post-Acute Coronary Syndrome Patients with Type-2 Diabetes

scientific article published on 13 April 2020

Galectin-3, a biomarker linking oxidative stress and inflammation with the clinical outcomes of patients with atherothrombosis

artículo científico publicado en 2014

Genetic deletion or TWEAK blocking antibody administration reduce atherosclerosis and enhance plaque stability in mice

artículo científico publicado en 2014

Glomerular haematuria, renal interstitial haemorrhage and acute kidney injury

artículo científico publicado en 2010

HMG-CoA Reductase Inhibitors Decrease Angiotensin II–Induced Vascular Fibrosis

artículo científico publicado en 2007

HMG-CoA reductase inhibitors reduce I kappa B kinase activity induced by oxidative stress in monocytes and vascular smooth muscle cells.

artículo científico publicado en 2005

HMGB1 expression and secretion are increased via TWEAK-Fn14 interaction in atherosclerotic plaques and cultured monocytes

artículo científico publicado en 2013

HSP90 inhibition by 17-DMAG attenuates oxidative stress in experimental atherosclerosis

scientific journal article

Heat shock protein 90 inhibitors attenuate inflammatory responses in atherosclerosis

artículo científico publicado en 2010

Heat-shock proteins in cardiovascular disease

artículo científico publicado en 2011

Hemoglobin induces monocyte recruitment and CD163-macrophage polarization in abdominal aortic aneurysm

artículo científico publicado en 2015

Hyperlipidemia-associated renal damage decreases Klotho expression in kidneys from ApoE knockout mice

artículo científico publicado en 2013

Identification by a differential proteomic approach of heat shock protein 27 as a potential marker of atherosclerosis

artículo científico publicado en 2004

Identification of novel biomarkers of abdominal aortic aneurysms by 2D-DIGE and MALDI-MS from AAA-thrombus-conditioned media.

artículo científico publicado en 2013

Identification of peroxiredoxin-1 as a novel biomarker of abdominal aortic aneurysm

artículo científico publicado en 2011

Identification of soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) as a possible biomarker of subclinical atherosclerosis

artículo científico publicado en 2007

Impact of soluble TWEAK and CD163/TWEAK ratio on long-term cardiovascular mortality in patients with peripheral arterial disease

artículo científico publicado en 2011

Improving metabolite knowledge in stable atherosclerosis patients by association and correlation of GC-MS and 1H NMR fingerprints

artículo científico publicado en 2009

Increased CD74 expression in human atherosclerotic plaques: contribution to inflammatory responses in vascular cells

artículo científico publicado en 2009

Increased galectin-3 levels are associated with abdominal aortic aneurysm progression and inhibition of galectin-3 decreases elastase-induced AAA development

artículo científico publicado en 2017

Increased levels of thioredoxin in patients with abdominal aortic aneurysms (AAAs). A potential link of oxidative stress with AAA evolution

artículo científico publicado en 2010

Increased plasma levels of NGAL, a marker of neutrophil activation, in patients with abdominal aortic aneurysm

artículo científico publicado en 2011

Increased soluble Fas plasma levels in subjects at high cardiovascular risk: Atorvastatin on Inflammatory Markers (AIM) study, a substudy of ACTFAST

artículo científico publicado en 2006

Inflammatory biomarkers and statins

artículo científico publicado en 2005

Inflammatory biomarkers and statins.

artículo científico publicado en 2005

Intensive treatment with atorvastatin reduces inflammation in mononuclear cells and human atherosclerotic lesions in one month

artículo científico publicado en 2005

Intensive treatment with statins and the progression of cardiovascular diseases: the beginning of a new era?

artículo científico publicado en 2004

LDL induces parathyroid hormone-related protein expression in vascular smooth muscle cells: Modulation by simvastatin

artículo científico publicado en 2008

Label-free proteomic analysis of red blood cell membrane fractions from abdominal aortic aneurysm patients

artículo científico publicado en 2014

Leukotriene B4 enhances the activity of nuclear factor-kappaB pathway through BLT1 and BLT2 receptors in atherosclerosis

artículo científico publicado en 2008

Lipocalin-2 deficiency or blockade protects against aortic abdominal aneurysm development in mice

artículo científico publicado en 2016

Lipophilic statins induce apoptosis of human vascular smooth muscle cells

artículo científico publicado en 1999

Low plasma levels of HSP70 in patients with carotid atherosclerosis are associated with increased levels of proteolytic markers of neutrophil activation

artículo científico publicado en 2006

Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Lowering With Atorvastatin in Patients of South Asian Compared With European Origin: Insights From the Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration

article

Macrophage Cholesterol Efflux Downregulation Is Not Associated with Abdominal Aortic Aneurysm (AAA) Progression

scientific article published on 24 April 2020

Mechanisms of action of statins in stroke

artículo científico publicado en 2007

Monocyte Chemoattractant Protein-1 Is an Independent Predictor of Coronary Artery Ectasia in Patients with Acute Coronary Syndrome

scientific article published on 21 September 2020

N-Terminal Pro-Brain Natriuretic Peptide Is Associated with a Future Diagnosis of Cancer in Patients with Coronary Artery Disease

artículo científico publicado en 2015

NF-kappaB activation and Fas ligand overexpression in blood and plaques of patients with carotid atherosclerosis: potential implication in plaque instability

artículo científico publicado en 2004

Olive oil and walnut breakfasts reduce the postprandial inflammatory response in mononuclear cells compared with a butter breakfast in healthy men.

artículo científico publicado en 2008

Overexpression of COX-2, Prostaglandin E synthase-1 and prostaglandin E receptors in blood mononuclear cells and plaque of patients with carotid atherosclerosis: regulation by nuclear factor-kappaB.

artículo científico publicado en 2005

Oxidative Stress in Human Atherothrombosis: Sources, Markers and Therapeutic Targets.

artículo científico publicado en 2017

Oxidative Stress, Macrophage Infiltration and CD163 Expression Are Determinants of Long-Term Renal Outcome in Macrohematuria-Induced Acute Kidney Injury of IgA Nephropathy

artículo científico publicado en 2012

Paraoxonase-1 overexpression prevents experimental abdominal aortic aneurysm progression

artículo científico publicado en 2016

Parathormone Levels Are Independently Associated with the Presence of Left Ventricular Hypertrophy in Patients with Coronary Artery Disease.

artículo científico publicado en 2016

Peripheral Artery Disease Is Associated With a High CD163/TWEAK Plasma Ratio

Phase IV prospective clinical study to evaluate the effect of taurine on liver function in postsurgical adult patients requiring parenteral nutrition.

artículo científico publicado en 2014

Plasma Levels of Monocyte Chemoattractant Protein-1, n-Terminal Fragment of Brain Natriuretic Peptide and Calcidiol Are Independently Associated with the Complexity of Coronary Artery Disease

artículo científico publicado en 2016

Plasma fingerprinting with GC-MS in acute coronary syndrome

artículo científico publicado en 2009

Plasma profiling by a protein array approach identifies IGFBP-1 as a novel biomarker of abdominal aortic aneurysm.

artículo científico publicado en 2012

Proteomic Analysis of Polymorphonuclear Neutrophils Identifies Catalase as a Novel Biomarker of Abdominal Aortic Aneurysm: Potential Implication of Oxidative Stress in Abdominal Aortic Aneurysm Progression

article

Proteomic analysis of intraluminal thrombus highlights complement activation in human abdominal aortic aneurysms.

artículo científico publicado en 2013

Proteomic and metabolomic profiles in atherothrombotic vascular disease

artículo científico publicado en 2010

Proteomic approach in the search of new cardiovascular biomarkers

artículo científico publicado en 2005

Proteomic strategies in the search of new biomarkers in atherothrombosis

artículo científico publicado en 2010

Proteomics and metabolomics in biomarker discovery for cardiovascular diseases: progress and potential.

artículo científico publicado en 2016

Proteomics in atherosclerosis.

artículo científico publicado en 2008

Proteomics in atherothrombosis: a future perspective

artículo científico publicado en 2007

Quantitative HDL Proteomics Identifies Peroxiredoxin-6 as a Biomarker of Human Abdominal Aortic Aneurysm.

scientific article published on 09 December 2016

Quest for novel cardiovascular biomarkers by proteomic analysis.

artículo científico publicado en 2005

Red wine intake prevents nuclear factor-kappaB activation in peripheral blood mononuclear cells of healthy volunteers during postprandial lipemia.

artículo científico publicado en 2000

Reduced sTWEAK and increased sCD163 levels in HIV-infected patients: modulation by antiretroviral treatment, HIV replication and HCV co-infection

artículo científico publicado en 2014

Simvastatin reduces NF-kappaB activity in peripheral mononuclear and in plaque cells of rabbit atheroma more markedly than lipid lowering diet

artículo científico publicado en 2003

Soluble Fas ligand plasma levels are associated with forearm reactive hyperemia in subjects with coronary artery disease: a novel biomarker of endothelial function?

artículo científico publicado en 2008

Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD.

artículo científico publicado en 2016

Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes

artículo científico publicado en 2011

Soluble TWEAK and atheromatosis progression in patients with chronic kidney disease

artículo científico publicado en 2017

Soluble TWEAK is associated with atherosclerotic burden in patients with chronic kidney disease

artículo científico publicado en 2013

Soluble TWEAK levels predict the presence of carotid atherosclerotic plaques in subjects free from clinical cardiovascular diseases.

artículo científico publicado en 2015

Soluble TWEAK plasma levels as a novel biomarker of endothelial function in patients with chronic kidney disease

artículo científico publicado en 2009

Soluble TWEAK plasma levels increase after renal transplantation and associate with the improvement of endothelial function

artículo científico publicado en 2013

Soluble TWEAK plasma levels predict expansion of human abdominal aortic aneurysms

scientific article published on 12 November 2010

Statin use in aortic aneurismal disease to prevent progression and cardiovascular events: review of experimental and clinical data C

artículo científico publicado en 2013

Statins in hypertensive patients: potential explanations for the ASCOT-LLA study results

artículo científico publicado en 2004

Statins to prevent cardiovascular events in hypertensive patients. The ASCOT-LLA study

artículo científico publicado en 2004

TWEAK activates the non-canonical NFkappaB pathway in murine renal tubular cells: modulation of CCL21

artículo científico publicado en 2010

TWEAK and Fn14. New players in the pathogenesis of atherosclerosis

artículo científico publicado en 2007

TWEAK and the kidney: the dual role of a multifunctional cytokine.

scientific article published on January 2011

TWEAK blockade decreases atherosclerotic lesion size and progression through suppression of STAT1 signaling in diabetic mice

artículo científico publicado en 2017

TWEAK promotes peritoneal inflammation

artículo científico publicado en 2014

TWEAK-Fn14 interaction enhances plasminogen activator inhibitor 1 and tissue factor expression in atherosclerotic plaques and in cultured vascular smooth muscle cells

scientific article published on 01 September 2010

TWEAK/Fn14 Axis: A Promising Target for the Treatment of Cardiovascular Diseases.

scientific article published on 20 January 2014

TWEAK/Fn14 interaction promotes oxidative stress through NADPH oxidase activation in macrophages

artículo científico publicado en 2015

TWEAKing renal injury

artículo científico publicado en 2008

Targeted gold-coated iron oxide nanoparticles for CD163 detection in atherosclerosis by MRI.

artículo científico publicado en 2015

Targeting chemokines in proteinuria-induced renal disease

artículo científico

The CD163-expressing macrophages recognize and internalize TWEAK: potential consequences in atherosclerosis.

artículo científico publicado en 2009

The Prognostic Value of High-Sensitive Troponin I in Stable Coronary Artery Disease Depends on Age and Other Clinical Variables.

artículo científico publicado en 2015

The Rho-kinase pathway regulates angiotensin II-induced renal damage.

artículo científico publicado en 2005

The chronic intake of a Mediterranean diet enriched in virgin olive oil, decreases nuclear transcription factor kappaB activation in peripheral blood mononuclear cells from healthy men

scientific article published on 03 January 2007

The cytokine TWEAK modulates renal tubulointerstitial inflammation

artículo científico publicado en 2008

The proteomic approach in the development of prognostic biomarkers in atherothrombosis

artículo científico publicado en 2009

Thioredoxin-1/peroxiredoxin-1 as sensors of oxidative stress mediated by NADPH oxidase activity in atherosclerosis

artículo científico publicado en 2015

Trail and vascular injury

artículo científico publicado en 2007

Treatment with amlodipine and atorvastatin has additive effect on blood and plaque inflammation in hypertensive patients with carotid atherosclerosis.

artículo científico publicado en 2008

Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (TWEAK)/Fibroblast Growth Factor-Inducible 14 (Fn14) Axis in Cardiovascular Diseases: Progress and Challenges

artículo científico publicado en 2020

Tumor Necrosis Factor–Like Weak Inducer of Apoptosis (TWEAK) Enhances Vascular and Renal Damage Induced by Hyperlipidemic Diet in ApoE-Knockout Mice

artículo científico publicado en 2009

Tumor necrosis factor-like weak inducer of apoptosis or Fn14 deficiency reduce elastase perfusion-induced aortic abdominal aneurysm in mice.

artículo científico publicado en 2014

Tweak induces proliferation in renal tubular epithelium: a role in uninephrectomy induced renal hyperplasia

artículo científico publicado en 2009

Usefulness of a combination of monocyte chemoattractant protein-1, galectin-3, and N-terminal probrain natriuretic peptide to predict cardiovascular events in patients with coronary artery disease

artículo científico publicado en 2013

Vascular protection of dual therapy (atorvastatin-amlodipine) in hypertensive patients

artículo científico publicado en 2006

Vascular proteomics and the discovery process of clinical biomarkers: The case of TWEAK.

artículo científico publicado en 2011

Vascular proteomics, a translational approach: from traditional to novel proteomic techniques.

artículo científico publicado en 2009

Vasoprotective effects of statins and angiotensin II blockers in atherothrombosis

artículo científico publicado en 2005

[Atorvastatin inhibits the atherosclerotic lesion induced by tumor necrosis factor-like weak inducer of apoptosis in apolipoprotein E deficient mice]

artículo científico publicado en 2014

[Impact of plasma pro-B-type natriuretic peptide amino-terminal and galectin-3 levels on the predictive capacity of the LIPID Clinical Risk Scale in stable coronary disease]

artículo científico publicado en 2014

[Statins, inflammation and atherosclerotic damage]

artículo científico publicado en 2004

[TWEAK, the facilitator of acute kidney injury]

artículo científico publicado en 2008

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda